Riluzole
ریلوزول
🧠 Nervous SystemGlutamate inhibitor
Market / country: 🇺🇸 USA
Rilutek (US)
🧮 Dose calculator
Amyotrophic lateral sclerosis (ALS) · Regimen source: FDA Riluzole · 2
- • Check aminotransferases before and during treatment. FDA Riluzole · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ History of severe hypersensitivity to riluzole (anaphylaxis has occurred). FDA Riluzole · 4
Warnings
- • Hepatic injury (not recommended if ALT >5× ULN); neutropenia (report fever); interstitial lung disease. FDA Riluzole · 5
Formulations
- 50 mg tablet — tablet 🇺🇸 USA FDA Riluzole · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Riluzole · 8.1
“Risk Summary There are no studies of riluzole in pregnant women, and case reports have been inadequate to inform the drug-associated risk.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Riluzole · 8.2
“Risk Summary It is not known if riluzole is excreted in human milk.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Riluzole · 8.4
“Safety and effectiveness of riluzole tablets in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Riluzole · 8.5
“In clinical studies of riluzole tablets, 30% of patients were 65 years and over.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Riluzole · 8.3
“In rats, oral administration of riluzole resulted in decreased fertility indices and increases in embryolethality [see Nonclinical Toxicology (13.1)].”
🔗 Reference links
- FDA (approval record)ANDA206045
- DailyMed (FDA label)FDA Riluzole
- MedlinePlus (NIH)Riluzole
- WHO ATC/DDDN07XX02
- Darooyab (Iran)Riluzole
🇮🇷 Registered in Iran Darooyab · G-4181/Riluzole
Dosage forms with Iranian generic codes, per Darooyab.
- 01921 · RILUZOLE 50MG TAB · قرص ریلوزول ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Riluzole · 3FDA Riluzole · 2FDA Riluzole · 4FDA Riluzole · 5FDA Riluzole · SPL approval / marketing categoryFDA Riluzole · 8.1FDA Riluzole · 8.2FDA Riluzole · 8.4FDA Riluzole · 8.5FDA Riluzole · 8.3
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-4181/Riluzole
- Clinical review⚠ Unverified